Salivary gland tumor primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
According to the United States Preventive Services Task Force, screening for uveal melanoma is not recommended.<ref name=screening>http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=VIPoma. Accessed on October 19, 2015.</ref>
According to the United States Preventive Services Task Force, screening for uveal melanoma is not recommended.<ref name=screening>http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=VIPoma. Accessed on October 19, 2015.</ref>
==Screening==
==Screening==
According to the United States Preventive Services Task Force, screening for uveal melanoma is not recommended.
Salivary gland cancer behaves differently in each person, and a standard follow-up schedule would not work for everyone. People with salivary gland cancer should talk to their doctor about a follow-up plan that suits their individual situation. Follow-up care is often shared among the cancer specialists (oncologists) and the family doctor.
 
After treatment has ended, new symptoms and symptoms that don't go away should be reported to the doctor without waiting for the next scheduled appointment. These may include:
 
any new lump or swelling
pain or an increase in pain
difficulty swallowing
The chance of salivary gland cancer recurring is greatest within the first 2–3 years, so close follow-up is needed during this time. Because salivary gland cancer can return many years later, lifelong follow-up is necessary.
 
Schedule
 
Follow-up after salivary gland cancer treatment varies. Follow-up visits are usually scheduled:
 
every 6–8 weeks for the first year
every 2–3 months in the second year
every 3–4 months in the third year
then every 6–12 months for life
Procedures
 
During a follow-up visit, the doctor usually asks questions about the side effects of treatment and how the person is coping. The doctor may do a complete physical examination, including:
 
examining the site of surgery
feeling the neck lymph nodes for any swelling
asking about numbness or weakness of the facial muscles
Tests may be ordered as part of follow-up or if the doctor suspects the cancer has come back (has recurred).
 
A chest x-ray may be done every 6 months for the first 2–3 years after treatment to see if the cancer has spread to the lungs.
If a recurrence is found during follow-up, the oncology team will assess the person with cancer to determine the best treatment options.
 
 
 
Read more: http://www.cancer.ca/en/cancer-information/cancer-type/salivary-gland/treatment/follow-up/?region=sk#ixzz3rCnIDBjb
== References ==  
== References ==  
{{reflist|2}}
{{reflist|2}}

Revision as of 17:40, 11 November 2015

Uveal melanoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveal melanoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salivary gland tumor primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salivary gland tumor primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salivary gland tumor primary prevention

CDC on Salivary gland tumor primary prevention

Salivary gland tumor primary prevention in the news

Blogs on Salivary gland tumor primary prevention

to Hospitals Treating Uveal melanoma

Risk calculators and risk factors for Salivary gland tumor primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

According to the United States Preventive Services Task Force, screening for uveal melanoma is not recommended.[1]

Screening

Salivary gland cancer behaves differently in each person, and a standard follow-up schedule would not work for everyone. People with salivary gland cancer should talk to their doctor about a follow-up plan that suits their individual situation. Follow-up care is often shared among the cancer specialists (oncologists) and the family doctor.

After treatment has ended, new symptoms and symptoms that don't go away should be reported to the doctor without waiting for the next scheduled appointment. These may include:

any new lump or swelling pain or an increase in pain difficulty swallowing The chance of salivary gland cancer recurring is greatest within the first 2–3 years, so close follow-up is needed during this time. Because salivary gland cancer can return many years later, lifelong follow-up is necessary.

Schedule

Follow-up after salivary gland cancer treatment varies. Follow-up visits are usually scheduled:

every 6–8 weeks for the first year every 2–3 months in the second year every 3–4 months in the third year then every 6–12 months for life Procedures

During a follow-up visit, the doctor usually asks questions about the side effects of treatment and how the person is coping. The doctor may do a complete physical examination, including:

examining the site of surgery feeling the neck lymph nodes for any swelling asking about numbness or weakness of the facial muscles Tests may be ordered as part of follow-up or if the doctor suspects the cancer has come back (has recurred).

A chest x-ray may be done every 6 months for the first 2–3 years after treatment to see if the cancer has spread to the lungs. If a recurrence is found during follow-up, the oncology team will assess the person with cancer to determine the best treatment options.


Read more: http://www.cancer.ca/en/cancer-information/cancer-type/salivary-gland/treatment/follow-up/?region=sk#ixzz3rCnIDBjb

References

Template:WH Template:WS